Evaluation of Pirfenidone as a New Postoperative Antiscarring Agent in Experimental Glaucoma Surgery
Investigative Ophthalmology & Visual Science2011Vol. 52(6), pp. 3136–3136
Citations Over TimeTop 10% of 2011 papers
Abstract
Postoperative use of 0.5% pirfenidone eye drops was associated with improved trabeculectomy bleb survival in a rabbit model. Pirfenidone eye drops may be a safe and effective antiscarring agent in glaucoma filtration surgery.
Related Papers
- → Comparative Evaluation of Trabeculotomy-Trabeculectomy with Mitomycin C vs Trabeculectomy, with Mitomycin C for Primary Congenital Glaucoma(2011)10 cited
- → Bleb Morphology Assessment and Imaging(2008)3 cited
- Comparison of surgical outcomes of primary trabeculectomy with mitomycin C versus repeat trabeculectomy with mitomycin C(2004)
- [A case of encapsulated filtering bleb after trabeculectomy].(1995)
- → The comparative analysis of the formation of functional filtration bleb in different incision of scleral flap after trabeculectomy(2012)